BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 30 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,692 | +23.2% | 4,737,000 | +25.1% | 0.01% | +40.0% |
| Q2 2023 | $3,808 | +20.4% | 3,788,000 | +24.9% | 0.01% | +25.0% |
| Q1 2023 | $3,163 | -41.3% | 3,033,000 | -39.5% | 0.00% | -42.9% |
| Q4 2022 | $5,385 | -99.9% | 5,011,000 | -7.8% | 0.01% | -12.5% |
| Q3 2022 | $5,397,000 | -13.8% | 5,434,000 | -13.8% | 0.01% | 0.0% |
| Q2 2022 | $6,264,000 | -7.1% | 6,303,000 | -6.4% | 0.01% | +14.3% |
| Q1 2022 | $6,743,000 | +6.9% | 6,734,000 | +11.3% | 0.01% | +16.7% |
| Q4 2021 | $6,310,000 | -17.0% | 6,049,000 | -20.3% | 0.01% | -25.0% |
| Q3 2021 | $7,599,000 | -0.1% | 7,593,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $7,608,000 | – | 7,593,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 52,096 | $55,672 | 3.77% |
| MACKAY SHIELDS LLC | 77,043,000 | $83,172,605 | 2.12% |
| Sonora Investment Management Group, LLC | 7,960,000 | $8,654,409 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 12,390,000 | $17,994,379 | 0.73% |
| BRAIDWELL LP | 19,200,000 | $20,727,568 | 0.70% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,064,000 | $34,615,044 | 0.60% |
| LOOMIS SAYLES & CO L P | 2,089,754 | $216,269 | 0.43% |
| Liberty Mutual Group Asset Management Inc. | 825,000 | $887 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,386,583 | 0.09% |
| THRIVENT FINANCIAL FOR LUTHERANS | 15,950,000 | $17,139 | 0.04% |